Trademark: 97207472
Status Code
Status Date
Thursday, January 13, 2022
Serial Number
Mark Type
Filing Date
Friday, January 7, 2022

Trademark Owner History

5 Cells for medical use; Protein RNA complexes for medical use; DNA and RNA for medical use; DNA and RNA vectors for medical use; and DNA and RNA plasmids for medical use
42 Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Gene editing for developing cells and protein RNA complexes for medical use
Color is not claimed as a feature of the mark.
The mark consists of a stylized double helix design which incorporates a stylized letter S.

Trademark Events
Jan 14, 2022
Notice Of Design Search Code E-Mailed
Jan 13, 2022
New Application Office Supplied Data Entered In Tram
Jan 11, 2022
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24